MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Gamma Hydroxybutyric Acid.
Acepromazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Aceprometazine.
Acetazolamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Acetazolamide.
Aclidinium
The risk or severity of adverse effects can be increased when Aclidinium is combined with Butorphanol.
Alfaxalone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Alfaxalone.
Alfentanil
Butorphanol may decrease the analgesic activities of Alfentanil.
Alphaprodine
Butorphanol may decrease the analgesic activities of Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Butorphanol.
Alvimopan
The risk or severity of adverse effects can be increased when Butorphanol is combined with Alvimopan.
Alvimopan Anhydrous
The risk or severity of adverse effects can be increased when Butorphanol is combined with Alvimopan.
Amiloride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amiloride.
Amisulpride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amitriptyline.
Ammonium Chloride
Ammonium chloride may increase the excretion rate of Butorphanol which could result in a lower serum level and potentially a reduction in efficacy.
Amobarbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amoxapine.
Amphetamine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amphetamine.
Aripiprazole
The risk or severity of adverse effects can be increased when Butorphanol is combined with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Asenapine.
Atracurium
The risk or severity of adverse effects can be increased when Atracurium is combined with Butorphanol.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Butorphanol.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Butorphanol.
Azelastine
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azosemide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Azosemide.
Baclofen
The risk or severity of adverse effects can be increased when Butorphanol is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Barbital.
Benactyzine
The risk or severity of adverse effects can be increased when Benactyzine is combined with Butorphanol.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Benzocaine.
Benzphetamine
Benzphetamine may increase the analgesic activities of Butorphanol.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Butorphanol.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Benzyl alcohol.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Butorphanol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Butorphanol is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Bromazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bromazepam.
Bromotheophylline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bromotheophylline.
Bromperidol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Brotizolam.
Bumetanide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Bupivacaine.
Buprenorphine
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Butorphanol.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Butorphanol.
Butalbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Butorphanol is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Butethal.
Butylscopolamine
The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Butorphanol.
Canrenoate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Canrenoic acid.
Canrenoic Acid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Canrenoic acid.
Canrenone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Canrenone.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Butorphanol.
Carbinoxamine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Carisoprodol.
Cetirizine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Butorphanol.
Chlormethiazole
The risk or severity of adverse effects can be increased when Butorphanol is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chloroprocaine.
Chlorothiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorothiazide.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorphenamine.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Butorphanol.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Butorphanol.
Chlorprothixene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorprothixene.
Chlorthalidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Chlorzoxazone.
Cicletanine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cicletanine.
Citalopram
Butorphanol may increase the serotonergic activities of Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clonidine.
Clopamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clopamide.
Clorazepate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Butorphanol is combined with Clorazepate.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Butorphanol.
Cocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cocaine.
Codeine
Butorphanol may decrease the analgesic activities of Codeine.
Codeine Anhydrous
Butorphanol may decrease the analgesic activities of Codeine.
CODEINE POLISTIREX
Butorphanol may decrease the analgesic activities of Codeine.
Conivaptan
The risk or severity of adverse effects can be increased when Butorphanol is combined with Conivaptan.
Cyclizine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyclobenzaprine.
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyclopenthiazide.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Butorphanol.
Cyclothiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyclothiazide.
Cyproheptadine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cyproheptadine.
Dantrolene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dapiprazole.
Darifenacin
The risk or severity of adverse effects can be increased when Darifenacin is combined with Butorphanol.
Desflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Butorphanol.
Desmopressin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Desmopressin.
Desvenlafaxine
Butorphanol may increase the serotonergic activities of Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dexbrompheniramine.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Butorphanol.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may increase the analgesic activities of Butorphanol.
Dextromoramide
Butorphanol may decrease the analgesic activities of Dextromoramide.
Dezocine
Butorphanol may decrease the analgesic activities of Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Cinchocaine.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Butorphanol.
Diethylpropion
Diethylpropion may increase the analgesic activities of Butorphanol.
Difenoxin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Difenoxin.
Dihydrocodeine
Butorphanol may decrease the analgesic activities of Dihydrocodeine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Diphenhydramine.
Diphenoxylate
Butorphanol may decrease the analgesic activities of Diphenoxylate.
Doxepin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Drospirenone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Drospirenone.
Duloxetine
Butorphanol may increase the serotonergic activities of Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Butorphanol is combined with Efavirenz.
Eluxadoline
Butorphanol may increase the constipating activities of Eluxadoline.
Enflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Entacapone.
Eplerenone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Eplerenone.
Escitalopram
Butorphanol may increase the serotonergic activities of Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butorphanol.
Ethacrynate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Etacrynic acid.
Ethanol
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethyl loflazepate.
Ethylmorphine
Butorphanol may decrease the analgesic activities of Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Felbamate.
Fentanyl
Butorphanol may decrease the analgesic activities of Fentanyl.
Fesoterodine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Butorphanol.
Fexofenadine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fexofenadine.
Flavoxate
The risk or severity of adverse effects can be increased when Flavoxate is combined with Butorphanol.
Flavoxate Hydrochloride
The risk or severity of adverse effects can be increased when Flavoxate is combined with Butorphanol.
Flibanserin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flunitrazepam.
Fluoxetine
Butorphanol may increase the serotonergic activities of Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fluticasone propionate.
Fluvoxamine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fospropofol.
Furazolidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Furazolidone.
Furosemide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Furosemide.
Gabapentin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Butorphanol is combined with Gabapentin Enacarbil.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Butorphanol.
Glutethimide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Glutethimide.
Glycopyrronium
The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Butorphanol.
Guanfacine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Butorphanol.
Halothane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Halothane.
Heroin
Butorphanol may decrease the analgesic activities of Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Hexobarbital.
Homatropine
The risk or severity of adverse effects can be increased when Homatropine is combined with Butorphanol.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Hydrochlorothiazide.
Hydrocodone
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Hydroflumethiazide.
Hydromorphone
Butorphanol may decrease the analgesic activities of Hydromorphone.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Butorphanol.
Iloperidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Imipramine.
Indapamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Indapamide.
Ipratropium
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Butorphanol.
Ipratropium cation
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Butorphanol.
Iproniazid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Iproniazid.
Isocarboxazid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Isoflurane.
Isosorbide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Isosorbide.
Ketamine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lamotrigine.
Levetiracetam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Butorphanol is combined with Levodopa.
Levomethadyl
Butorphanol may decrease the analgesic activities of Levomethadyl Acetate.
Levomilnacipran
Butorphanol may increase the serotonergic activities of Levomilnacipran.
Levorphanol
Butorphanol may decrease the analgesic activities of Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may increase the analgesic activities of Butorphanol.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may increase the analgesic activities of Butorphanol.
Lithium
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lithium.
Lofexidine
The therapeutic efficacy of Butorphanol can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Butorphanol.
Lormetazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Butorphanol.
Lurasidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Butorphanol can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Butorphanol can be increased when used in combination with Magnesium sulfate.
Mannitol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Mannitol.
Maprotiline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Maprotiline.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Butorphanol.
Meclizine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Melatonin.
Meperidine
Butorphanol may decrease the analgesic activities of Pethidine.
Mephentermine
Mephentermine may increase the analgesic activities of Butorphanol.
Mephobarbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Butorphanol.
Mersalyl
The risk or severity of adverse effects can be increased when Butorphanol is combined with Mersalyl.
Mesoridazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Metaxalone.
Methadone
Butorphanol may decrease the analgesic activities of Methadone.
Methadyl Acetate
Butorphanol may decrease the analgesic activities of Methadyl Acetate.
Methamphetamine
Methamphetamine may increase the analgesic activities of Butorphanol.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Butorphanol.
Methapyrilene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methaqualone.
Methazolamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methazolamide.
Methixene
The risk or severity of adverse effects can be increased when Metixene is combined with Butorphanol.
Methocarbamol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Butorphanol.
Methotrimeprazine
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methoxyflurane.
Methscopolamine
The risk or severity of adverse effects can be increased when Methscopolamine is combined with Butorphanol.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Butorphanol.
Methsuximide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methsuximide.
Methyclothiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methyclothiazide.
Methylene blue
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methylene blue.
Methylnaltrexone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Methylnaltrexone.
Metolazone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Metolazone.
Metylperon
The risk or severity of adverse effects can be increased when Butorphanol is combined with Melperone.
Metyrosine
Butorphanol may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Midazolam.
Milnacipran
Butorphanol may increase the serotonergic activities of Milnacipran.
Minaprine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Minaprine.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Mirtazapine
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Moclobemide.
Molindone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Molindone.
Moricizine
Moricizine may increase the hypotensive activities of Butorphanol.
Morphine
Butorphanol may decrease the analgesic activities of Morphine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Nalbuphine
Butorphanol may decrease the analgesic activities of Nalbuphine.
Naloxegol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Naloxegol.
Naltrexone
The therapeutic efficacy of Butorphanol can be decreased when used in combination with Naltrexone.
Nefazodone
Butorphanol may increase the serotonergic activities of Nefazodone.
Nialamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nialamide.
Nitrazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nitrous oxide.
Nordazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Norflurane.
Normethadone
Butorphanol may decrease the analgesic activities of Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Nortriptyline.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Butorphanol.
Octylonium
The risk or severity of adverse effects can be increased when Otilonium is combined with Butorphanol.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Butorphanol.
Olopatadine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ondansetron.
Opium
Butorphanol may decrease the analgesic activities of Opium.
Orphenadrine
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxazepam.
Oxitropium
The risk or severity of adverse effects can be increased when Oxitropium is combined with Butorphanol.
Oxprenolol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Oxprenolol.
Oxybutynin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Butorphanol.
Oxycodone
Butorphanol may decrease the analgesic activities of Oxycodone.
Oxymorphone
Butorphanol may decrease the analgesic activities of Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Butorphanol.
p-Hydroxyamphetamine
Hydroxyamphetamine may increase the analgesic activities of Butorphanol.
Paliperidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Paliperidone.
Pancuronium
The risk or severity of adverse effects can be increased when Pancuronium is combined with Butorphanol.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Butorphanol.
Paraldehyde
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
Butorphanol may decrease the analgesic activities of Morphine.
Pargyline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pargyline.
Paroxetine
Butorphanol may increase the serotonergic activities of Paroxetine.
Pegvisomant
The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Butorphanol.
Pentazocine
Butorphanol may decrease the analgesic activities of Pentazocine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Butorphanol.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Perazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Perazine.
Periciazine
Propericiazine may increase the hypotensive activities of Butorphanol.
Perphenazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Phenelzine.
Phenobarbital
The risk or severity of adverse effects can be increased when Butorphanol is combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Phenoxyethanol.
Phentermine
Phentermine may increase the analgesic activities of Butorphanol.
PHENTERMINE RESIN
Phentermine may increase the analgesic activities of Butorphanol.
Phenytoin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pipamperone.
Pipecuronium
The risk or severity of adverse effects can be increased when Pipecuronium is combined with Butorphanol.
Pipothiazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pipotiazine.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Butorphanol.
Piretanide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Piretanide.
Pirinitramide
Butorphanol may decrease the analgesic activities of Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pizotifen.
Polythiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pomalidomide.
Potassium
The risk or severity of adverse effects can be increased when Butorphanol is combined with Potassium.
Potassium Citrate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Potassium Citrate.
Potassium Ion
The risk or severity of adverse effects can be increased when Butorphanol is combined with Potassium.
Pramipexole
Butorphanol may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Butorphanol can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Procarbazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Butorphanol.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Butorphanol.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Butorphanol.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Butorphanol.
Promethazine
Promethazine may increase the hypotensive activities of Butorphanol.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Butorphanol.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Butorphanol.
Proparacaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Proparacaine.
Propiverine
The risk or severity of adverse effects can be increased when Propiverine is combined with Butorphanol.
Propofol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Propofol.
Propoxyphene
Butorphanol may decrease the analgesic activities of Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Protriptyline.
Pseudoephedrine
Pseudoephedrine may increase the analgesic activities of Butorphanol.
Quazepam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Quetiapine.
Quinethazone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Quinethazone.
Quinidine
The risk or severity of adverse effects can be increased when Quinidine is combined with Butorphanol.
Ramelteon
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ramelteon.
Rasagiline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Rasagiline.
Remifentanil
Butorphanol may decrease the analgesic activities of Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Butorphanol.
Rilpivirine
The serum concentration of Butorphanol can be decreased when it is combined with Rilpivirine.
Risperidone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Risperidone.
Ropinirole
Butorphanol may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ropivacaine.
Rotigotine
Butorphanol may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Butorphanol.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Butorphanol.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Butorphanol.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Butorphanol.
Selegiline
The risk or severity of adverse effects can be increased when Butorphanol is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Butorphanol is combined with Sertindole.
Sertraline
Butorphanol may increase the serotonergic activities of Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Sevoflurane.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Butorphanol.
Spironolactone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Spironolactone.
Succinylcholine
Succinylcholine may increase the bradycardic activities of Butorphanol.
Sufentanil
Butorphanol may decrease the analgesic activities of Sufentanil.
Sulpiride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Sulpiride.
Suvorexant
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Tasimelteon
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tasimelteon.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Butorphanol.
Tetrabenazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.
Thalidomide
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theobromine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Theobromine.
Thiamylal
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Butorphanol.
Thiopental
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiopental.
Thioproperazine
Thioproperazine may increase the hypotensive activities of Butorphanol.
Thioridazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tiapride.
Tiotropium
The risk or severity of adverse effects can be increased when Tiotropium is combined with Butorphanol.
Tizanidine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tolcapone.
Toloxatone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Toloxatone.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Butorphanol.
Tolvaptan
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tolvaptan.
Topiramate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Topiramate.
Torsemide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Torasemide.
Tramadol
Butorphanol may decrease the analgesic activities of Tramadol.
Tranylcypromine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Trazodone.
Triamterene
The risk or severity of adverse effects can be increased when Butorphanol is combined with Triamterene.
Triazolam
The risk or severity of adverse effects can be increased when Butorphanol is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Loprazolam.
Trichlormethiazide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Triflupromazine.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Butorphanol.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Butorphanol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Butorphanol.
Trimethaphan
The risk or severity of adverse effects can be increased when Trimethaphan is combined with Butorphanol.
Trimipramine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Triprolidine.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Butorphanol.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Butorphanol.
Tubocurarine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Butorphanol.
Umeclidinium
The risk or severity of adverse effects can be increased when Umeclidinium is combined with Butorphanol.
Urethane
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Butorphanol is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Butorphanol is combined with Valproic Acid.
Vecuronium
The risk or severity of adverse effects can be increased when Vecuronium is combined with Butorphanol.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Butorphanol.
Venlafaxine
Butorphanol may increase the serotonergic activities of Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Butorphanol is combined with Vigabatrin.
Vortioxetine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Butorphanol.
Zolpidem
Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Zuclopenthixol.
